Jane Wasman
2017
In 2017, Jane Wasman earned a total compensation of $1.3M as President, International, General Counsel and Corporate Secretary at Acorda Therapeutics, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $172,640 |
|---|---|
| Option Awards | $165,434 |
| Salary | $568,267 |
| Stock Awards | $343,438 |
| Other | $7,950 |
| Total | $1,257,729 |
Wasman received $568.3K in salary, accounting for 45% of the total pay in 2017.
Wasman also received $172.6K in non-equity incentive plan, $165.4K in option awards, $343.4K in stock awards and $8K in other compensation.
Rankings
In 2017, Jane Wasman's compensation ranked 7,878th out of 14,666 executives tracked by ExecPay. In other words, Wasman earned more than 46.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,878 out of 14,666 | 46th |
Division Manufacturing | 2,957 out of 5,772 | 49th |
Major group Chemicals And Allied Products | 966 out of 2,075 | 53rd |
Industry group Drugs | 752 out of 1,731 | 57th |
Industry Biological Products, Except Diagnostic Substances | 140 out of 313 | 55th |
Source: SEC filing on April 26, 2019.
Wasman's colleagues
We found five more compensation records of executives who worked with Jane Wasman at Acorda Therapeutics in 2017.
2017
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2017
Andrew Hindman
Acorda Therapeutics
Chief Business Officer
2017
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2017
Burkhard Blank
Acorda Therapeutics
Chief Medical Officer
2017
David Lawrence
Acorda Therapeutics